Replimune Group (REPL) Stock: Buy, Sell, or Hold?
REPL - Replimune Group, Inc.
$13.45
0.21 (1.59%)
▲
5d:
+6.75%
30d:
-14.17%
90d:
+19.88%
HOLD
LOW Confidence
Analysis Updated: Oct 1, 2026 12:00 AM ET
Earnings: Nov 05, 2026
Get Alerted When REPL Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
📊 HOLD: REPL shows balanced signals. Fine to hold or accumulate slowly. Monitor for clearer direction.
📊 HOLD: REPL shows balanced signals. Fine to hold or accumulate slowly. Monitor for clearer direction.
In-depth Analysis How we analyze
Valuation Analysis: REPL is currently trading at $13.45, which is considered fair relative to its 30-day fair value range of $12.76 to $15.21.
Technical Outlook: Technically, REPL is in a strong uptrend. The price is approaching resistance at $13.66. A breakout above this level would be a bullish signal, while rejection here could lead to consolidation.
Market Sentiment: REPL scores 83/100 on our bottoming-setup gauge — the chart has corrected and is stabilizing (RSI reset, momentum turning up), historically a favorable entry zone. Wall Street analysts see significant upside, with an average price target of $19.50 (+45.0%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Technical Outlook: Technically, REPL is in a strong uptrend. The price is approaching resistance at $13.66. A breakout above this level would be a bullish signal, while rejection here could lead to consolidation.
Market Sentiment: REPL scores 83/100 on our bottoming-setup gauge — the chart has corrected and is stabilizing (RSI reset, momentum turning up), historically a favorable entry zone. Wall Street analysts see significant upside, with an average price target of $19.50 (+45.0%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Quick Decision Summary
Current Position
FAIR
Historical Trading Range
$12.76 -
$15.21
Company Quality Score
63/100
(BUY)
Volume Confirmation
HIGH
Confidence Score
86.8%
Protect Your Profits
Holding REPL? Use our AI-powered strategies to protect your downside while keeping your long-term position.
View Profit Protection PlanAll Signals
- NEUTRAL: Price in fair range
- BULLISH: Strong technical setup (83/100)
- BULLISH: High volume confirmation
- BULLISH: Trading 45.0% below Wall St target ($19.50)
- CAUTION: Bottoming setup, but lagging the sector by 28% over 20 days — wait for relative strength
Trading Range Analysis
30-Day Trading Range
$12.76 -
$15.21
Current vs Trading Range
FAIR
Support & Resistance Levels
Support Level
$12.07
Resistance Level
$13.66
Current Trend
Strong Uptrend
Technical data as of
Oct 1, 2026
Fundamental Context
Forward P/E (Next Year Est.)
-6.45
Wall Street Target
$19.50
(+45.0%)
Share & Embed Analysis
Last updated: October 02, 2026 7:09 AM ET
Data refreshes hourly during market hours. Next update: 8:09 AM
Data refreshes hourly during market hours. Next update: 8:09 AM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is REPL showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
BMRN
Biomarin Pharmaceutical … |
STRONG BUY
29 analysts |
$92 | 59 HOLD |
|
DNLI
Denali Therapeutics Inc |
STRONG BUY
19 analysts |
$36 | 63 BUY |
|
BBIO
BridgeBio Pharma Inc |
STRONG BUY
19 analysts |
$109 | 73 BUY |
|
NRIX
Nurix Therapeutics Inc |
STRONG BUY
18 analysts |
$34 | 61 BUY |
|
AXSM
Axsome Therapeutics Inc |
STRONG BUY
19 analysts |
$285 | 44 HOLD |
Advanced REPL Option Strategies
Professional options setups generated by AI based on today's REPL price and gamma walls.
